Clinically silent relapsing malaria may still pose a threat

Credit: CC0 Public Domain

Nonhuman primates with clinically undetectable Plasmodium relapse infections still harbor parasitic gametocytes that may be infectious to mosquitoes, according to a study published September 19 in the open-access journal PLOS Pathogens by F. Eun-Hyung Lee and Mary R. Galinski of Emory University, Tracey J. Lamb of the University of Utah, and colleagues. The study has important epidemiological implications relevant to malaria elimination strategies.

The protozoal parasite Plasmodium vivax is a major cause of —a life-threatening mosquito-borne disease responsible for hundreds of thousands of deaths globally each year. P. vivax remains a major obstacle for malaria elimination due to its ability to form dormant stages in the liver. These forms can become activated to cause relapsing blood-stage infections. Relapses remain poorly understood because it is difficult to verify whether P. vivax blood-stage infections in patients are due to new infections or relapses. To address this gap in knowledge, researchers used a nonhuman primate model of malaria, combined with state-of-the-art immunological and molecular techniques, to assess pathogenesis, host responses, and circulating gametocyte levels during relapses.

They found that relapses were clinically silent compared to initial infections, and they were associated with a robust memory B cell response. This response resulted in the production of antibodies that were able to mediate clearance of relapsing, asexual parasites. Despite this rapid immune protection, the sexual-stage gametocytes, which may be infectious to mosquitoes, continued to circulate. According to the authors, the number of clinically silent infections, and their infectiousness to mosquitoes, remains largely unknown and should be evaluated carefully in the future. As a next step on the path to eliminating P. vivax and other relapsing malaria parasites, studies should identify the factors that influence relapse pathogenesis, immunity, and infectiousness to mosquitoes.

"This study shows the explicit benefit of using a nonhuman primate model system to study the and relate the findings to human clinical cases and transmission," states Dr. Galinski. "It is important to know that asymptomatic individuals may carry infectious gametocytes."

Dr. Lamb adds, "This study reveals the role of B cells in the control of relapsing malaria."

Finally Dr. Lee adds, "The nonhuman primate model is ideal to study the true memory B cell responses during relapsing malaria because this question is difficult to answer in ."

Explore further

Monkey malaria breakthrough offers cure for relapsing malaria

More information: Joyner CJ, Brito CFA, Saney CL, Joice Cordy R, Smith ML, Lapp SA, et al. (2019) Humoral immunity prevents clinical malaria during Plasmodium relapses without eliminating gametocytes. PLoS Pathog 15(9): e1007974.
Journal information: PLoS Pathogens

Citation: Clinically silent relapsing malaria may still pose a threat (2019, September 19) retrieved 17 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more